Eris Lifesciences Limited

Eris Lifesciences schedules analyst and investor call for October 26, 2026, to discuss Q2 and H1 FY2027 results. The call is scheduled for 4:30 PM IST and requires pre-registration via a provided Zoom

Eris Lifesciences board to consider Q2 September 2026 unaudited financial results on October 26, 2026. Trading window closed from October 1, 2026, until 48 hours post-results declaration per SEBI norm